Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure

This study seeks to investigate the clinical value of novel echocardiographic indices, including myocardial work parameters, during the acute phase of heart failure hospitalization. The trajectory of novel echocardiographic indices from the start to the end of hospitalization will be captured, as a means to unravel and subsequently better understand the diverse pathophysiology of different phenotypes of the heart failure continuum. Correlation between novel echocardiographic indices with clinical data, biochemical data, different heart failure phenotypes, and therapeutic maneuvers will be attempted. Prognostic implications of those indices will be explored.

NCT Number	NCT05573997
Lead Sponsor	Aristotle University Of Thessaloniki
Conditions	Cardiovascular Diseases, Heart Failure, Valvular Heart Disease, Biochemical Dysfunction
Enrollment	300 participants
Start Date	2022-04-10
Primary Completion	2024-12-10 (estimated)
Study Completion	2025-01-10 (estimated)
Updated on ClinicalTrials.gov	2024-07-31